Stericycle (NASDAQ: SRCL) recently received a number of ratings updates from brokerages and research firms:

  • 9/22/2016 – Stericycle had its price target lowered by analysts at Wedbush from $95.00 to $85.00. They now have a “neutral” rating on the stock.
  • 9/20/2016 – Stericycle was downgraded by analysts at Northcoast Research from a “buy” rating to a “neutral” rating.
  • 9/20/2016 – Stericycle was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong sell” rating. According to Zacks, “Stericycle has a negative earnings surprise history, having missed estimates twice in the trailing four quarters. The recent spate of acquisitions is leading to higher overheads and integration-related expenses, which are weighing on margins. The company faces aggressive price wars that erode its profitability. Evolving environmental rules and regulations remain another headwind. Stericycle also lowered its earnings guidance for 2016 due to macroeconomic challenges. In the past, the company was forced to reduce prices for LQ customers due to competitive pressures, which could be repeated in the future. This forces us to be bearish on the stock to some extent. However, Stericycle’s network is the largest in the industry and provides it with routing efficiencies for its vehicles from the customer sites to the collection and processing facilities. This network is difficult to replicate and allow Stericycle to compete effectively.”
  • 9/19/2016 – Stericycle had its price target lowered by analysts at Royal Bank Of Canada from $89.00 to $77.00. They now have an “underperform” rating on the stock.
  • 9/19/2016 – Stericycle had its “underperform” rating reaffirmed by analysts at RBC Capital Markets. They now have a $77.00 price target on the stock, down previously from $89.00.
  • 9/9/2016 – Stericycle had its price target lowered by analysts at Imperial Capital from $93.50 to $80.00. They now have an “underperform” rating on the stock.
  • 9/7/2016 – Stericycle had its “buy” rating reaffirmed by analysts at Jefferies Group. They now have a $112.50 price target on the stock, down previously from $125.00.
  • 8/25/2016 – Stericycle is now covered by analysts at Macquarie. They set a “neutral” rating and a $96.00 price target on the stock.
  • 8/23/2016 – Stericycle had its “buy” rating reaffirmed by analysts at Jefferies Group. They now have a $125.00 price target on the stock.
  • 7/29/2016 – Stericycle was downgraded by analysts at Imperial Capital from an “in-line” rating to an “underperform” rating. They now have a $93.50 price target on the stock, down previously from $100.00.
  • 7/29/2016 – Stericycle was downgraded by analysts at Wellington Shields from an “accumulate” rating to a “hold” rating.
  • 7/29/2016 – Stericycle had its “buy” rating reaffirmed by analysts at Jefferies Group. They now have a $125.00 price target on the stock, down previously from $140.00.
  • 7/25/2016 – Stericycle was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Stericycle’s network is the largest in the industry and provides it with routing efficiencies for its vehicles from the customer sites to the collection and processing facilities. This network is difficult to replicate and the lower costs further allow Stericycle to compete effectively on both service and price. International growth rates are expected to accelerate due to increasing customer adoption of multiple services and expansion into new lines of business. However, the recent spate of acquisitions is leading to higher overheads and integration-related expenses, which are weighing on margins. The company also faces aggressive price wars that erode its profitability. Evolving environmental rules and regulations remain another headwind. The earnings estimates have remained stable over the last month as it focuses on strategic acquisitions to expand the business. Stericycle has a mixed earnings history in the recent quarters.”

Shares of Stericycle Inc. (NASDAQ:SRCL) opened at 78.00 on Thursday. The firm has a 50-day moving average of $84.48 and a 200-day moving average of $102.42. Stericycle Inc. has a 52 week low of $76.76 and a 52 week high of $151.57. The firm has a market cap of $6.63 billion, a PE ratio of 27.46 and a beta of 0.27.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, July 28th. The company reported $1.18 earnings per share for the quarter, meeting the consensus estimate of $1.18. The company earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. Stericycle’s revenue for the quarter was up 24.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.14 EPS. On average, analysts expect that Stericycle Inc. will post $4.67 EPS for the current year.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/analysts-weekly-ratings-changes-for-stericycle-srcl.html

In other Stericycle news, Director Mark C. Miller sold 34,835 shares of the business’s stock in a transaction on Friday, July 8th. The shares were sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the completion of the sale, the director now owns 244,284 shares in the company, valued at approximately $25,532,563.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John P. Schetz sold 1,398 shares of the business’s stock in a transaction on Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the sale, the executive vice president now owns 1,088 shares of the company’s stock, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by insiders.

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with MarketBeat.com's FREE daily email newsletter.